German Software Stock News

As European markets navigate recent declines, with the STOXX Europe 600 Index down 2.54% and major indices like Germany's DAX and France's CAC 40 experiencing notable drops, investors are increasingly focused on defensive sectors amid geopolitical tensions. In this environment, identifying promising small-cap stocks that can withstand market volatility becomes crucial; these "undiscovered gems" often offer unique growth opportunities driven by innovative business models or niche market...

We feel now is a pretty good time to analyse Singulus Technologies AG's ( ETR:SNG ) business as it appears the company...

Why adidas (XTRA:ADS) is back on investor watchlists adidas (XTRA:ADS) has attracted fresh attention after a mixed run in the share price, with a return of around 4% over the past month but a decline of about 6% in the past 3 months. That share performance sits against annual revenue of €24.8b and net income of €1.3b. This combination is prompting investors to reassess how the current valuation lines up with recent business trends and long term return potential. See our latest analysis for...

Siemens (XTRA:SIE) is expanding its Global AI Manufacturing Technologies R&D Center for battery production in Canada with support from a significant Canadian government investment. The company has also secured a competitively awarded, multi year U.S. government security contract through Siemens Government Technologies. These public private partnerships connect Siemens to AI enabled manufacturing and battery research, as well as long term federal security work in the U.S. For you as an...

Nordex (XTRA:NDX1) has opened Q1 2026 reporting season with a reference point of €2.54b in Q4 2025 revenue and basic EPS of €0.78, capping a trailing twelve month period where EPS reached €1.16 and revenue came in at about €7.55b. Over recent quarters, the company has seen revenue move from €2.19b in Q4 2024 to €2.54b in Q4 2025 while basic EPS shifted from €0.07 to €0.78, alongside trailing year net income of €274.45m. This has set up a results story where higher profitability and a 3.6% net...

flatexDEGIRO (XTRA:FTK) has drawn attention after its recent share price swings, with a 1 day return of about a 10% decline and a 7 day move of nearly a 21% decline, prompting closer scrutiny from investors. See our latest analysis for flatexDEGIRO. The recent share price weakness sits against a mixed backdrop, with a 30 day share price return of 2.63% but a 90 day share price return of 24.70% decline. At the same time, the 1 year total shareholder return of 40.53% and 3 year total...

Recent share performance and current snapshot Continental (XTRA:CON) has seen mixed share performance, with a 1 day return of around a 1% decline and a 7 day move of about a 2% decline, while the past month shows roughly 10% growth. Over the past 3 months, the stock is down about 2%, and year to date it is lower by around 4%. Over the past year, however, the total return stands near 28%, and around 46% over 3 years, in contrast with a slightly negative 5 year total return. At the last close...

Recent share performance and financial snapshot PUMA (XTRA:PUM) has caught investor attention after a recent share price move, with the stock up about 16% over the past month and around 6% over the past 3 months, while longer term returns remain weaker. At a last close of €25.00 and a market value near €3.68b, the company reports annual revenue of about €7.30b alongside a net loss of roughly €673.9m, reflecting a mixed financial picture. See our latest analysis for PUMA. The recent 16.4% 1...

As geopolitical tensions and economic uncertainties weigh on European markets, the pan-European STOXX Europe 600 Index has recently experienced a decline, with defensive sectors like utilities and telecoms showing relative strength. In this environment, identifying undervalued stocks becomes crucial for investors seeking opportunities to capitalize on potential market mispricings.

Delivery Hero (XTRA:DHER) has put artificial intelligence at the center of its tech story with Herogen, an in-house autonomous coding agent that already produces output comparable to 130 senior engineers. See our latest analysis for Delivery Hero. The share price is at €19.50 and the 30 day share price return of 17.33% sits against a year to date share price decline of 14.55% and a 1 year total shareholder return decline of 26.61%. This suggests that recent momentum contrasts with weaker...

Dividend increase and upcoming earnings call draw focus Frequentis (XTRA:FQT) has attracted fresh attention after announcing an annual dividend of €0.30 per share, alongside scheduling its 2025 earnings call for April 23, 2026. This gives investors two near term information points. See our latest analysis for Frequentis. Frequentis shares trade at €76.80 after a 2.54% 1 day share price gain and a 7.87% 30 day share price return. The 1 year total shareholder return of 105.39% and 5 year total...

Q1 2026 earnings set the tone for Sartorius Sartorius (XTRA:SRT3) has put its recent Q1 2026 earnings in focus, reporting sales of €899.1 million and net income of €56.2 million. The company also confirmed its full year guidance and provided commentary on operational momentum. See our latest analysis for Sartorius. The latest Q1 update and recent conference presence have not yet translated into sustained share price strength. A 30 day share price return of 4.98% compares with a 12.39% decline...

SAP (XTRA:SAP) is back in focus after its Q1 2026 earnings, where cloud growth, higher profitability and early AI traction with Joule drew investor attention and coincided with renewed interest in the stock. See our latest analysis for SAP. The Q1 2026 update comes after a tough few months for shareholders, with the share price at €147.28 and a 90 day share price return showing a 26.71% decline, while the 5 year total shareholder return of 36.94% still reflects longer term value creation. If...

If you are wondering whether Commerzbank's current share price really reflects its value, you are not alone. A closer look at the numbers can help you frame that question more clearly. The stock last closed at €33.94, with returns of 11.1% over the past 30 days and 51.7% over the past year, alongside a 5.9% decline over the last week and a 6.8% decline year to date. Recent headlines around Commerzbank have focused on its position in the German banking sector and its progress on internal...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Münchener...

RATIONAL Aktiengesellschaft ( ETR:RAA ) stock is about to trade ex-dividend in 3 days. The ex-dividend date generally...

Readers hoping to buy GEA Group Aktiengesellschaft ( ETR:G1A ) for its dividend will need to make their move shortly...

Porsche (XTRA:P911) has agreed to sell its entire equity stakes in Bugatti Rimac and Rimac Group. The transaction hands operational control of Bugatti Rimac to Rimac Group and brings in a new investor group led by HOF Capital and BlueFive Capital. The exit reflects Porsche’s focus on its core automotive operations and a reshaping of ownership in high end sports car brands. For you as an investor, this move indicates that Porsche is concentrating resources on its main business of premium...

If you are wondering whether Sixt is offering value at its current share price, or if you are better off waiting on the sidelines, this article walks through what the numbers say about the stock. Sixt recently closed at €70.65, with returns of 12.1% over the past month, but an 11.9% decline over the last year and a 27.6% decline over three years, which may have shifted how investors view both its potential and its risks. Recent coverage has focused on Sixt's share price performance and how...

Wondering whether Fresenius Medical Care at around €38.84 is starting to look attractive or still expensive compared to its fundamentals? This article focuses squarely on what you are getting for the current price. The stock has been relatively muted in the short term, with a 1.8% decline over the last 7 days and a 1.1% gain over the last 30 days, while the 1 year return sits at a 6.9% decline and the 5 year return at a 33.4% decline. Recent coverage around Fresenius Medical Care has largely...

Bayer (XTRA:BAYN) has recently drawn investor attention after reporting annual revenue of €45.575b alongside a net loss of €3.620b. This has prompted fresh questions about how its three core segments support the current share price. See our latest analysis for Bayer. Despite the latest results, Bayer’s recent 1-day share price return of a 3.85% decline and 7-day share price return of a 6.33% decline suggest near-term sentiment has cooled, while the 1-year total shareholder return of 68.27%...

Wondering if PUMA at around €25 a share still offers value, or if the easy gains are already behind it? This article walks through what the current price may be implying about the business. The stock has returned 13.8% over the last 30 days and 11.6% year to date, although the 12.9% return over the last year sits against a much weaker 3 year return of 49.8% and a 5 year return of 69.3%. Recent coverage has focused on how PUMA fits into the global sportswear and athleisure space, including...

How SAP (XTRA:SAP) Entered Q1 2026 on the Back of Its Recent Numbers SAP (XTRA:SAP) heads into its Q1 2026 reporting cycle with investors already digesting recent quarterly figures, including Q4 2025 revenue of about €9.7b and basic EPS of €1.44. Over the last six reported quarters, the company has seen revenue move from €8.5b in Q3 2024 to €9.7b in Q4 2025, while basic EPS over that same span ranged between €1.25 and €1.72 per quarter. This gives a clear view of how the top and bottom line...

LANXESS stock in focus after recent performance shift LANXESS (XTRA:LXS) has come into focus after a recent price move, with the shares closing at €18.06 and showing positive returns over the past month, while longer term performance remains weaker. See our latest analysis for LANXESS. Recent trading has been mixed, with a 10.32% 1 month share price return and a modest 3.08% year to date share price return set against a 29.24% 1 year total shareholder return decline. This suggests short term...